Celon Pharma SA's total assets for Q4 2025 were zł457.46M, a decrease of -2.94% from the previous quarter. PL:CLN total liabilities were zł74.47M for the fiscal quarter, a -9.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.